Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of seattle heart failure model in patients with chronic heart failure

American Journal of Cardiology

Volumn 107, Issue 8, 2011, Pages 1185-1190

  Kuramoto, Yuki ^a   Yamada, Takahisa ^a   Tamaki, Shunsuke ^b   Okuyama, Yuji ^a   Morita, Takashi ^a   Furukawa, Yoshio ^a   Tanaka, Koji ^a   Iwasaki, Yusuke ^a   Yasui, Taku ^a   Ueda, Hiromichi ^a   Okada, Takeshi ^a   Kawasaki, Masato ^a   Levy, Wayne C ^c   Komuro, Issei ^b   Fukunami, Masatake ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ALDOSTERONE ANTAGONIST; ALLOPURINOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SCINTIANGIOGRAPHY; SCORING SYSTEM;

3-IODOBENZYLGUANIDINE; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; WASHINGTON;

EID: 79953241955     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.12.019     Document Type: Article

References (25)

1. The SOLVED Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure N Engl J Med 325 1991 293 302
2. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, A.B. Cropp, I. Anand, A. Maggioni, P. Burton, M.D. Sullivan, B. Pitt, P.A. Poole-Wilson, D.L. Mann, and M. Packer The Seattle heart failure model: prediction of survival in heart failure Circulation 113 2006 1424 1433 (Pubitemid 43739439)
3. D.M. Wieland, L.E. Brown, W.L. Rogers, K.C. Worthington, J.L. Wu, N.H. Clinthorne, C.A. Otto, D.P. Swanson, and W.H. Beierwaltes Myocardial imaging with a radioiodinated norepinephrine storage analog J Nucl Med 22 1981 22 31 (Pubitemid 11213140)
4. J. Schofer, R. Spielmann, A. Schuchert, K. Weber, and M. Schluter Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 12 1988 1252 1258
5. P. Merlet, H. Valette, J.-L. Dubois-Rande, D. Moyse, D. Duboc, P. Dove, M.H. Bourguignon, C. Benvenuti, A.M. Duval, and D. Agostini Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 1992 471 477
6. P. Merlet, C. Benvenuti, D. Moyse, F. Pouillart, J.L. Dubois-Rand, A.M. Duval, D. Loisance, A. Castaigne, and A. Syrota Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy J Nucl Med 40 1999 917 923 (Pubitemid 29269210)
7. T. Yamada, T. Shimonagata, M. Fukunami, K. Kumagai, H. Ogita, A. Hirata, M. Asai, N. Makino, H. Kioka, H. Kusuoka, M. Hori, and N. Hoki Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study J Am Coll Cardiol 41 2003 231 238 (Pubitemid 36092191)
8. Y. Imamura, and T. Fukuyama Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathyimportance of background correction for quantification of MIBG activity Ann Nucl Med 16 2002 387 393 (Pubitemid 35407627)
9. H. Kioka, T. Yamada, T. Mine, T. Morita, Y. Tsukamoto, S. Tamaki, M. Masuda, K. Okuda, M. Hori, and M. Fukunami Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging Heart 93 2007 1213 1218 (Pubitemid 47492905)
10. 123I-mIBG imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF study J Am Coll Cardiol 55 2010 2212 2221
11. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
12. M. Packer, C.M. O'Connor, and J.K. Ghali Effect of amlodipine on morbidity and mortality in severe chronic heart failure: Prospective Randomized Amlodipine Survival Evaluation Study Group N Engl J Med 335 1996 1107 1114 (Pubitemid 26330964)
13. B. Pitt, P.A. Poole-Wilson, R. Segal, F.A. Martinez, K. Dickstein, A.J. Camm, M.A. Konstam, G. Riegger, G.H. Klinger, J. Neaton, D. Sharma, and B. Thiyagarajan Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trialthe Losartan Heart Failure Survival Study Elite II Lancet 355 2000 1582 1587 (Pubitemid 30240502)
14. M.D. Sullivan, W.C. Levy, B.A. Crane, J.E. Russo, and J.A. Spertus Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure Am J Cardiol 94 2004 1577 1580 (Pubitemid 40268470)
15. J.N. Cohn, and G. Tognoni A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675 (Pubitemid 33126822)
16. D.L. Mann, J.J. McMurray, M. Packer, K. Swedberg, J.S. Borer, W.S. Colucci, J. Djian, H. Drexler, A. Feldman, L. Kober, H. Krum, P. Liu, M. Nieminen, L. Tavazzi, D.J. van Veldhuisen, A. Waldenstrom, M. Warren, A. Westheim, F. Zannad, and T. Fleming Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602 (Pubitemid 38451714)
17. A.P. Maggioni, C. Opasich, I. Anand, S. Barlera, E. Carbonieri, L. Gonzini, L. Tavazzi, R. Latini, and J. Cohn Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice J Card Fail 11 2005 91 98 (Pubitemid 40269782)
18. H. Ogita, T. Shimonagata, M. Fukunami, K. Kumagai, T. Yamada, Y. Asano, A. Hirata, M. Asai, H. Kusuoka, M. Hori, and N. Hoki Prognostic significance of cardiac I-123 metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study Heart 86 2001 656 660 (Pubitemid 33086883)
19. A. Foti, S. Kimura, V. DeQuattro, and D. Lee Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine Clin Chem 33 1987 2209 2213
20. G.J. Hasking, M.D. Esler, G.L. Jennings, D. Burton, J.A. Johns, and P.I. Korner Norepinephrine spillover to plasma in congestive heart failure: evidence of increased cardiorenal and total sympathetic nerve activity Circulation 73 1986 615 621 (Pubitemid 16081418)
21. S. Tamaki, T. Yamada, Y. Okuyama, T. Morita, S. Sanada, Y. Tsukamoto, M. Masuda, K. Okuda, Y. Iwasaki, T. Yasui, M. Hori, and M. Fukunami Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction J Am Coll Cardiol 53 2009 426 435
22. J.N. Cohn, B.T. Levine, M.T. Olivari, V. Garberg, D. Lura, G.S. Francis, A.B. Simon, and T. Rector Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure N Engl J Med 311 1984 819 823 (Pubitemid 14035089)
23. D. Mozaffarian, S.D. Anker, I. Anand, D.T. Linker, M.D. Sullivan, J.G. Cleland, P.E. Carson, A.P. Maggioni, D.L. Mann, B. Pitt, P.A. Poole-Wilson, and W.C. Levy Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 2007 392 398 (Pubitemid 47196544)
24. W.C. Levy, K.L. Lee, A.S. Hellkamp, J.E. Poole, D. Mozaffarian, D.T. Linker, A.P. Maggioni, I. Anand, P.A. Poole-Wilson, D.P. Fishbein, G. Johnson, J. Anderson, D.B. Mark, and G.H. Bardy Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842
25. 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review Eur Heart J 29 2008 1147 1159 (Pubitemid 351844881)